Skip to main content
Polyoxyl 40 castor oil

VitiPure HCO 40 LEX

VitiPure HCO 40 is versatile non-ionic solubilizer and emulsifier enhancing the solubility and bioavailability of hydrophobic APIs and fat-soluble vitamins. VitiPure HCO 40 is obtained by reacting 40 moles of ethylene oxide with 1 mole of hydrogenated castor oil. At the room temperature it appears as white to yellowish paste. VitiPure HCO 40 is suitable for SEDDS and SMEDDS.

The LEX grade represents Low Endotoxins & Low bioburden grade product especially suitable for customers using it in high-risk applications.

 

Benefits
  • Includes the microbiology specifications: Endotoxin: max. 1 IU/ml; TAMC: max. 50 cfu/g TYMC: max. 50 cuf/g; Salmonella: absent; Staphylococcus aureus: absent; Escherichia coli: absent; Pseudomonas aeruginosa: absent
  • Ideal solubilizer for hydrophobic APIs and Vitamins.
  • Well established safety and toxicology via several marketed drugs worldwide
  • Suitable for SEDDS and SMEDDS formulations
Product details
Chemical Name
  • Polyoxyl 40 castor oil
Product Function
  • Solublizers
  • Surfactant
  • Emulsifier
Applications
VitiPure HCO 40 is a nonionic solubilizer and emulsifying agent. 
Generic name
Polyoxyl 40 Hydrogenated Castor Oil (USP), Macrogolglycerol Hydroxystearate (Ph. Eur.)
Grade

IPEC GMP Pharma (Parenteral) Grade

Country of Origin
Spain
Manufacturer address
Clariant Ibérica Producción S.A., Autovía Tarragona-Salou, Km. 3,8, 43110 La Canonja Tarragona, Spain
Packaging size (Article Nr.)
100kg steel drum (Article Nr. 32636731363, 32636731365) and 25kg steel drum (Article Nr. 32636731207); Sample size 0.5kg
Retest period
24 months

Download File

VitiPure HCO 40 LEX

Please choose one of the available product configurations:
No files are available for this product.

Login Required

Log in or register to ClariHub for our full set of ingredient documentation, formulations and more resources!
Log in or register to ClariHub for our full set of ingredient documentation, formulations and more resources!

Page summary

Summarization in progress